General Geriatrics
News, opinions and meeting coverage in geriatrics.
<ѻýҕl>Droxidopa for OH Slammed by FDA Reviewersѻýҕl>
SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.
Jan 13, 2014